SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks1Spatial Holdings Regulatory News (SPA)

  • This share is currently suspended. It was suspended at a price of 72.80
  • There is currently no data for SPA

Rule 8.1- (Xploite plc) - Replacement

12 Apr 2010 17:06

RNS Number : 0621K
Xploite PLC
12 April 2010
 



RULE 8 AMENDMENT

 

The 'Rule 8.1 - Xploite plc' announcement released on 12/04/2010 at 13.36 under RNS No 0390K has been amended.

 

Amendments are identified with an asterisk (*).

 

The full amended text is shown below.

 

 

FORM 8.1

 

DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES

FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

(Rules 8.1(a) and (b)(i) of the City Code on Takeovers and Mergers)

 

 

1...KEY INFORMATION

 

Name of person dealing (Note 1)

Ian Smith (Chief Executive)

Company dealt in

Xploite plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

10p Ordinary

Date of dealing

09/04/10

 

 

2...INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

4,070,575

18.7%

-

-

(2) Derivatives (other than options)

-

-

-

-

(3) Options and agreements to purchase/sell*

-

-

-

-

Total

4,070,575

18.7%

-

-

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

-

-

-

-

(2) Derivatives (other than options)

-

-

-

-

(3) Options and agreements to purchase/sell

-

-

-

-

Total

-

-

-

-

 

(c)..Rights to subscribe (Note 3)*

 

Class of relevant security:

Details

Ordinary Shares of 10p each

Call Option ('A' Options), which shall expire on 19 March 2017, are held in respect of 344,828 ordinary shares at an exercise price of 29p upon satisfaction of a share price performance condition of 58p.

 

3...DEALINGS (Note 4)

 

(a)..Purchases and sales

 

Purchase/sale

Number of securities

Price per unit (Note 5)

Purchase

220,513

36p

 

 

(b)..Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

 

 

n/a

 

 

(c)..Options transactions in respect of existing securities

(i)..Writing, selling, purchasing or varying

 

Product

name,e.g.

call option

Writing,

selling,

purchasing,

varying etc.

Number of

securities to

which the

option relates

(Note 7)

Exercise

price

Type, e.g.

American,

European

etc.

Expiry

date

Option money

paid/received

per unit (Note 5)

 

n/a

 

(ii)..Exercising

 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

n/a

 

(d)..Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

n/a

 

4...OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Further details of the rights to subscribe referred to above are available in the Scheme Document which is available in the investor relations section of the company's website: http://www.xploite.co.uk/investors/recommended-proposal.php

 

Is a Supplemental Form 8 attached? (Note 9)........ NO

 

Date of disclosure

12 April 2010

Contact name

Ian Smith

Telephone number

+44 (0) 870 737 2001

Name of offeree/offeror with which associated

Xploite plc

Specify category and nature of associate status (Note 10)

Director of Xploite plc

 

Notes

The Notes on Form 8.1 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCGGUQCCUPUGAP
Date   Source Headline
14th May 20197:00 amRNSFinal results for the year ended 31 January 2019
13th May 20192:50 pmRNSHolding(s) in Company
10th May 201911:23 amRNSHolding(s) in Company
8th May 20197:00 amRNSPlacing, Acquisition & Agreement with Esri
15th Mar 20197:00 amRNSTransfer of FTSE sector classification to Software
7th Mar 20197:00 amRNSTrading Update
5th Mar 20192:51 pmRNSHolding(s) in Company
20th Feb 20197:00 amRNS1Spatial Awarded Significant Contract
19th Feb 20197:00 amRNSAmendment to Enables IT Disposal Agreement
18th Jan 20197:00 amRNS1Spatial Awarded Significant Contracts
12th Dec 201811:37 amRNSDirector Shareholding
29th Nov 20189:30 amRNSHolding(s) in Company
1st Nov 20186:13 pmRNSHolding(s) in Company
30th Oct 20189:33 amRNSHolding(s) in Company
23rd Oct 20187:00 amRNSInterim Results
2nd Oct 20187:00 amRNSNotice of Results
20th Sep 20183:43 pmRNSDirector Share Purchase
7th Sep 201810:41 amRNSDirector Share Purchase
7th Sep 20187:00 amRNSDirector Share Purchase
5th Sep 20187:00 amRNSNew Long-Term Incentive Plan and Grant of Options
31st Aug 20184:56 pmRNSTotal Voting Rights
24th Aug 201810:06 amRNSDirector Share Purchase
23rd Aug 20182:48 pmRNSHolding(s) in Company
20th Aug 20183:19 pmRNSResult of General Meeting
31st Jul 20187:00 amRNSPosting of Circular & Related Party Transactions
26th Jul 20185:12 pmRNSResult of Placing
26th Jul 201811:06 amRNSClose of Accelerated Bookbuild
26th Jul 20187:00 amRNSLaunch Of Placing Via Accelerated Bookbuild
24th Jul 20181:00 pmRNSResult of AGM
10th Jul 20187:00 amRNSDirector Appointment
2nd Jul 20187:00 amRNSReport and Accounts and Notice of AGM
22nd May 20187:00 amRNSFinal results for the year ended 31 January 2018
9th May 20187:00 amRNSNotice of Results
3rd Apr 20187:00 amRNS1Spatial Awarded Significant Contract
15th Mar 20187:00 amRNSDirectorate Change
15th Mar 20187:00 amRNSTrading Update
15th Mar 20187:00 amRNSDisposal of Enables IT
11th Jan 20184:00 pmRNSHolding(s) in Company
10th Jan 20183:24 pmRNSHolding(s) in Company
9th Jan 20187:00 amRNS1Spatial Awarded US State Contract
4th Dec 20179:30 amRNSHolding(s) in Company
29th Nov 20176:23 pmRNSReplacement: Holding(s) in Company
29th Nov 201712:00 pmRNSHolding(s) in Company
24th Oct 201712:45 pmRNSHolding(s) in Company
10th Oct 20177:01 amRNSInterim Results
10th Oct 20177:00 amRNSDirectorate Changes
19th Sep 201711:24 amRNSHolding(s) in Company
14th Sep 20171:54 pmRNSNotice of Interim Results
14th Sep 20179:58 amEQSEdison Investment Research Limited: Edison issues outlook on 1Spatial (SPA)
14th Sep 20177:00 amRNSUS Contract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.